Literature DB >> 10717856

Shoulder impingement syndrome: preoperative health status.

L S Chipchase1, D A O'Connor, J J Costi, J Krishnan.   

Abstract

Eighty-one patients with chronic shoulder impingement resistant to conservative treatment completed a generic quality-of-life questionnaire (SF-36) and shoulder-specific questionnaire (Simple Shoulder Test [SST]). SF-36 data were compared with those of an Australian normative data set. Patients with chronic shoulder impingement were found to be significantly lower in all health dimensions of the SF-36 than the normal population. Results from the SST test indicated that patients were functionally very limited, particularly in being unable to work full time at their usual job and being unable to lift a weight above the head. Our results indicate that chronic shoulder impingement results in significant functional disability and a reduction in quality of life. Baseline descriptive data of this nature are important, because they provide a point of comparison for the effect of different conditions and for determining the effect of surgical treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10717856     DOI: 10.1016/s1058-2746(00)90003-x

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  16 in total

1.  Supraspinatus and infraspinatus weakness in overhead athletes with scapular dyskinesis: strength assessment before and after restoration of scapular musculature balance.

Authors:  Giovanni Merolla; Elisa De Santis; Fabrizio Campi; Paolo Paladini; Giuseppe Porcellini
Journal:  Musculoskelet Surg       Date:  2010-11-11

Review 2.  Treatment of impingement syndrome: a systematic review of the effects on functional limitations and return to work.

Authors:  Elske Faber; Judith I Kuiper; Alex Burdorf; Harald S Miedema; Jan A N Verhaar
Journal:  J Occup Rehabil       Date:  2006-03

3.  Quality of life assessments with SF 36 in different musculoskeletal diseases.

Authors:  Figen Yilmaz; Fusun Sahin; Ernur Ergoz; Emel Deniz; Cem Ercalik; Serap Dalgic Yucel; Banu Kuran
Journal:  Clin Rheumatol       Date:  2007-09-13       Impact factor: 2.980

4.  Analyses of possible risk factors for subacromial impingement syndrome.

Authors:  Boonsin Tangtrakulwanich; Anucha Kapkird
Journal:  World J Orthop       Date:  2012-01-18

5.  Comparison of open acromioplasty, arthroscopic acromioplasty and physiotherapy in patients with subacromial impingement syndrome: a prospective randomised study.

Authors:  Stefanos Farfaras; Ninni Sernert; Erling Hallström; Jüri Kartus
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-11       Impact factor: 4.342

6.  Patients who are candidates for subacromial decompression have more pronounced range of motion deficits, but do not differ in self-reported shoulder function, strength or pain compared to non-candidates.

Authors:  Adam Witten; Mikkel B Clausen; Kristian Thorborg; Mikkel L Attrup; Per Hölmich
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-17       Impact factor: 4.342

7.  Long-term patient satisfaction and functional outcome 8-11 years after subacromial decompression.

Authors:  Ingrid Hultenheim Klintberg; Ulla Svantesson; Jón Karlsson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-23       Impact factor: 4.342

8.  Shoulder activity level in the preoperative assessment of patients with rotator cuff tears.

Authors:  Sigitas Ryliskis; Robert H Brophy; Manvilius Kocius; Robert G Marx
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-12       Impact factor: 4.342

9.  Criterion validation of the rate of recovery, a single alphanumeric measure, in patients with shoulder pain.

Authors:  Bryan O'Halloran; Alexis Wright; Chad E Cook
Journal:  Int J Sports Phys Ther       Date:  2013-12

Review 10.  The association of scapular kinematics and glenohumeral joint pathologies.

Authors:  Paula M Ludewig; Jonathan F Reynolds
Journal:  J Orthop Sports Phys Ther       Date:  2009-02       Impact factor: 4.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.